tirzepatide court case today UPDATE [March 7, 2025]: OFA takes to appeals as legal battle evolves FDA's tirzepatide decision creates uncertainty – Compounding pharmacies can resume making

are currently taking GLP-1s, according to KFF, and 18% have taken the drugs at some point

, ,

Scientific Applications Research Areas Involving GHK-Cu Copper Peptide The scientific relevance of GHK-Cu Copper Peptide extends across numerous research disciplines

This episode is for: Trained lifters whove been told recomp is no longer on the table Coaches who want a clear framework for programming recomp phases Anyone stuck between cutting and bulking and ready to try a different approach Listeners who heard the Helms episode and want the practical playbook HERES WHAT WE COVER: A FOUNDATIONAL RECAP OF WHAT BODY RECOMP IS & THE 3 FORMS IT CAN TAKE A DEEP DIVE INTO THE LATEST RECOMP STUDY BY VARGAS-MOLINA ET AL